Literature DB >> 25126028

Resistant hypertension and untreated severe sleep apnea: slowly gaining insight.

Susan M Harding1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25126028      PMCID： PMC4106936          DOI： 10.5664/jcsm.3948

Source DB:  PubMed          Journal:  J Clin Sleep Med        ISSN： 1550-9389            Impact factor:   4.062


× No keyword cloud information.
  18 in total

1.  Association of severe obstructive sleep apnea and elevated blood pressure despite antihypertensive medication use.

Authors:  Harneet K Walia; Hong Li; Michael Rueschman; Deepak L Bhatt; Sanjay R Patel; Stuart F Quan; Daniel J Gottlieb; Naresh M Punjabi; Susan Redline; Reena Mehra
Journal:  J Clin Sleep Med       Date:  2014-08-15       Impact factor: 4.062

2.  High prevalence of unrecognized sleep apnoea in drug-resistant hypertension.

Authors:  A G Logan; S M Perlikowski; A Mente; A Tisler; R Tkacova; M Niroumand; R S Leung; T D Bradley
Journal:  J Hypertens       Date:  2001-12       Impact factor: 4.844

3.  Association between treated and untreated obstructive sleep apnea and risk of hypertension.

Authors:  José M Marin; Alvar Agusti; Isabel Villar; Marta Forner; David Nieto; Santiago J Carrizo; Ferran Barbé; Eugenio Vicente; Ying Wei; F Javier Nieto; Sanja Jelic
Journal:  JAMA       Date:  2012-05-23       Impact factor: 56.272

4.  Plasma aldosterone is related to severity of obstructive sleep apnea in subjects with resistant hypertension.

Authors:  Monique N Pratt-Ubunama; Mari K Nishizaka; Robyn L Boedefeld; Stacey S Cofield; Susan M Harding; David A Calhoun
Journal:  Chest       Date:  2007-02       Impact factor: 9.410

5.  Implications of small reductions in diastolic blood pressure for primary prevention.

Authors:  N R Cook; J Cohen; P R Hebert; J O Taylor; C H Hennekens
Journal:  Arch Intern Med       Date:  1995-04-10

6.  The impact of continuous positive airway pressure on blood pressure in patients with obstructive sleep apnea syndrome: evidence from a meta-analysis of placebo-controlled randomized trials.

Authors:  Patrick Haentjens; Alain Van Meerhaeghe; Antonio Moscariello; Sonia De Weerdt; Kris Poppe; Alain Dupont; Brigitte Velkeniers
Journal:  Arch Intern Med       Date:  2007-04-23

7.  Increased dietary sodium is related to severity of obstructive sleep apnea in patients with resistant hypertension and hyperaldosteronism.

Authors:  Eduardo Pimenta; Michael Stowasser; Richard D Gordon; Susan M Harding; Michel Batlouni; Bin Zhang; Suzanne Oparil; David A Calhoun
Journal:  Chest       Date:  2013-04       Impact factor: 9.410

8.  Efficacy of low-dose spironolactone in subjects with resistant hypertension.

Authors:  Mari Konishi Nishizaka; Mohammad Amin Zaman; David A Calhoun
Journal:  Am J Hypertens       Date:  2003-11       Impact factor: 2.689

9.  Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research.

Authors:  David A Calhoun; Daniel Jones; Stephen Textor; David C Goff; Timothy P Murphy; Robert D Toto; Anthony White; William C Cushman; William White; Domenic Sica; Keith Ferdinand; Thomas D Giles; Bonita Falkner; Robert M Carey
Journal:  Hypertension       Date:  2008-04-07       Impact factor: 10.190

Review 10.  Effect of nocturnal nasal continuous positive airway pressure on blood pressure in obstructive sleep apnea.

Authors:  Lydia A Bazzano; Zia Khan; Kristi Reynolds; Jiang He
Journal:  Hypertension       Date:  2007-06-04       Impact factor: 10.190
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.